Evaluation Confirms: QIAGEN's New GeneReader NGS System Delivers Valuable Clinical Insights
Go back to Evaluation Confirms: QIAGEN's New GeneReader NGS System Delivers Valuable Clinical Insights| Qiagen NV (NYSE: QGEN) | Delayed: 44.06 +0.67 (1.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.39 | 52 Week High | $28.50 | |||
| Open | $43.63 | 52 Week Low | $19.94 | |||
| Day High | $44.92 | P/E | 151.93 | |||
| Day Low | $43.63 | EPS | $0.29 | |||
| Volume | 644,087 | |||||
| (NYSE: QIA) | Delayed: 0.00 -10.35 (100%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.35 | 52 Week High | $ | |||
| Open | $10.35 | 52 Week Low | $ | |||
| Day High | $10.35 | P/E | N/A | |||
| Day Low | $10.35 | EPS | $ | |||
| Volume | 0 | |||||
